Guidance

Health service medical supplies costs

Information on the Health Service Medical Supplies (Costs) Bill.

Documents

Health Service Medical Supplies (Costs) Bill Impact Assessment

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk . Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Health Service Medical Supplies (Costs) Bill amends the National Health Service Act 2006 to:

  • put beyond doubt that the government can require companies to make payments to control the cost of health service medicines
  • enable the government to require companies to reduce the price of an unbranded generic medicine, or to impose other controls on that company’s unbranded medicine, even if the company is in the voluntary scheme (the Pharmaceutical Price Regulation Scheme) for their branded medicines
  • enable the government to make regulations to obtain information on sales and purchases of health service medicines, medical supplies and other related products from all parts of the supply chain, from manufacturer to pharmacy, for defined purposes

The factsheet provides more information on the measures in the Bill.

The impact assessment covers 2 individual impact assessments:

  • IA for the amendment of powers to enable the government to control the cost of health service medicines
  • IA for powers to enable the government to obtain information on medicines supplied to the health service

You can get more details on the Bill and its stages through Parliament on the Parliament website.

Published 15 September 2016
Last updated 8 November 2016 + show all updates
  1. Further details about the Health Service Medical Supplies (Costs) Bill have been added to the factsheet.
  2. First published.